Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.1 USD | -0.46% | -0.77% | +26.93% |
02/05 | Wedbush Raises SpringWorks Therapeutics' Price Target to $75 From $70, Keeps Outperform Rating | MT |
02/05 | SpringWorks Therapeutics Shares Fall After Wider-Than-Expected Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.93% | 3.43B | |
+9.82% | 106B | |
+0.95% | 104B | |
+6.72% | 23.25B | |
-13.75% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.87% | 16.99B | |
+8.24% | 14.26B | |
+38.99% | 12.76B |
- Stock Market
- Equities
- SWTX Stock
- News SpringWorks Therapeutics, Inc.
- Springworks Therapeutics : Working With Ab Magnitude on Next-Generation Oncology Therapeutics